Amarin Corp Plc (AMRN)

[ziploc_1]

Amarin seems to have given Eddingpharm near complete control of Vascepa in China...

QUOTE..."Under the agreement, Eddingpharm will be responsible for development and commercialization activities in the territory and associated expenses. Amarin will provide development assistance and be responsible for supplying finished, and later bulk, product."


" Terms of the agreement include up-front and milestone payments to Amarin of up to $169.0 million, including a non-refundable $15.0 million up-front payment and development, regulatory and sales-based milestone payments of up to an additional $154.0 million. Eddingpharm will also pay Amarin tiered double-digit percentage royalties on net sales of Vascepa in the territory escalating to the high teens. Amarin will supply product to Eddingpharm under negotiated supply terms."


What is left to be discovered is whether this deal between Amarin and Mochida allows Eddingpharm, as Amarin's licensee, to market MND-2119 in China...This is a product, which which Mochida is already pursuing in China with Sumimoto corp. as a partner.